<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39457114</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>20</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>21</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>New Evidence for the Role of the Blood-Brain Barrier and Inflammation in Stress-Associated Depression: A Gene-Environment Analysis Covering 19,296 Genes in 109,360 Humans.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">11332</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms252011332</ELocationID><Abstract><AbstractText>Mounting evidence supports the key role of the disrupted integrity of the blood-brain barrier (BBB) in stress- and inflammation-associated depression. We assumed that variations in genes regulating the expression and coding proteins constructing and maintaining this barrier, along with those involved in inflammation, have a predisposing or protecting role in the development of depressive symptoms after experiencing severe stress. To prove this, genome-by-environment (GxE) interaction analyses were conducted on 6.26 M SNPS covering 19,296 genes on PHQ9 depression in interaction with adult traumatic events scores in the UK Biobank (n = 109,360) in a hypothesis-free setup. Among the 63 genes that were significant in stress-connected depression, 17 were associated with BBB, 23 with inflammatory processes, and 4 with neuroticism. Compared to all genes, the enrichment of significant BBB-associated hits was 3.82, and those of inflammation-associated hits were 1.59. Besides some sex differences, <i>CSMD1</i> and <i>PTPRD</i>, encoding proteins taking part in BBB integrity, were the most significant hits in both males and females. In conclusion, the identified risk genes and their encoded proteins could provide biomarkers or new drug targets to promote BBB integrity and thus prevent or decrease stress- and inflammation-associated depressive symptoms, and possibly infection, e.g., COVID-19-associated mental and neurological symptoms.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gal</LastName><ForeName>Zsofia</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-9441-1497</Identifier><AffiliationInfo><Affiliation>Department of Pharmacodynamics, Faculty of Pharmaceutical Sciences, Semmelweis University, 1089 Budapest, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NAP3.0-SE Neuropsychopharmacology Research Group, Hungarian Brain Research Program, Semmelweis University, 1089 Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torok</LastName><ForeName>Dora</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pharmacodynamics, Faculty of Pharmaceutical Sciences, Semmelweis University, 1089 Budapest, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NAP3.0-SE Neuropsychopharmacology Research Group, Hungarian Brain Research Program, Semmelweis University, 1089 Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonda</LastName><ForeName>Xenia</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0001-9015-4203</Identifier><AffiliationInfo><Affiliation>NAP3.0-SE Neuropsychopharmacology Research Group, Hungarian Brain Research Program, Semmelweis University, 1089 Budapest, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, Semmelweis University, 1083 Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eszlari</LastName><ForeName>Nora</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pharmacodynamics, Faculty of Pharmaceutical Sciences, Semmelweis University, 1089 Budapest, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NAP3.0-SE Neuropsychopharmacology Research Group, Hungarian Brain Research Program, Semmelweis University, 1089 Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anderson</LastName><ForeName>Ian Muir</ForeName><Initials>IM</Initials><AffiliationInfo><Affiliation>Division of Neuroscience, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and Manchester Academic Health Sciences Centre, Manchester M13 9NT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deakin</LastName><ForeName>Bill</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Neuroscience, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and Manchester Academic Health Sciences Centre, Manchester M13 9NT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petschner</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Pharmacodynamics, Faculty of Pharmaceutical Sciences, Semmelweis University, 1089 Budapest, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NAP3.0-SE Neuropsychopharmacology Research Group, Hungarian Brain Research Program, Semmelweis University, 1089 Budapest, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bioinformatics Center, Institute of Chemical Research, Kyoto University, Uji, Kyoto 611-0011, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Unit for Realization of Sustainable Society, Kyoto University, Gokasho, Uji, Kyoto 611-0011, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Juhasz</LastName><ForeName>Gabriella</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pharmacodynamics, Faculty of Pharmaceutical Sciences, Semmelweis University, 1089 Budapest, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NAP3.0-SE Neuropsychopharmacology Research Group, Hungarian Brain Research Program, Semmelweis University, 1089 Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bagdy</LastName><ForeName>Gyorgy</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-8141-3410</Identifier><AffiliationInfo><Affiliation>Department of Pharmacodynamics, Faculty of Pharmaceutical Sciences, Semmelweis University, 1089 Budapest, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NAP3.0-SE Neuropsychopharmacology Research Group, Hungarian Brain Research Program, Semmelweis University, 1089 Budapest, Hungary.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2019-2.1.7-ERA-NET-2020-00005</GrantID><Agency>Hungarian National Research, Development, and Innovation Office</Agency><Country /></Grant><Grant><GrantID>K 143391, K 139330, PD 146014, and PD 134449 grants</GrantID><Agency>Hungarian National Research, Development, and Innovation Office</Agency><Country /></Grant><Grant><GrantID>NAP2022-I-4/2022</GrantID><Agency>Hungarian Brain Research Program 3.0</Agency><Country /></Grant><Grant><GrantID>TKP2021-EGA-25 and TKP2021-EGA-02</GrantID><Agency>Ministry of Innovation and Technology of Hungary from the National Research, Development and Innovation Fund</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001812" MajorTopicYN="Y">Blood-Brain Barrier</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="Y">Inflammation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="Y">Depression</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059647" MajorTopicYN="Y">Gene-Environment Interaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013315" MajorTopicYN="Y">Stress, Psychological</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="Y">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CSMD1</Keyword><Keyword MajorTopicYN="N">PTPRD</Keyword><Keyword MajorTopicYN="N">biomarkers</Keyword><Keyword MajorTopicYN="N">blood-brain barrier</Keyword><Keyword MajorTopicYN="N">depressive symptoms</Keyword><Keyword MajorTopicYN="N">negative life events</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest. depression. <i>Am J Psychiatry</i>
<b>2010</b>, <i>167</i>, 1254-1263. https://doi.org/10.1176/appi.ajp.2010.09091335.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39457114</ArticleId><ArticleId IdType="pmc">PMC11508422</ArticleId><ArticleId IdType="doi">10.3390/ijms252011332</ArticleId><ArticleId IdType="pii">ijms252011332</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Buch A.M., Liston C. Dissecting diagnostic heterogeneity in depression by integrating neuroimaging and genetics. Neuropsychopharmacology. 2021;46:156–175. doi: 10.1038/s41386-020-00789-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41386-020-00789-3</ArticleId><ArticleId IdType="pmc">PMC7688954</ArticleId><ArticleId IdType="pubmed">32781460</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonda X., Petschner P., Eszlari N., Baksa D., Edes A., Antal P., Juhasz G., Bagdy G. Genetic variants in major depressive disorder: From pathophysiology to therapy. Pharmacol. Ther. 2019;194:22–43. doi: 10.1016/j.pharmthera.2018.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2018.09.002</ArticleId><ArticleId IdType="pubmed">30189291</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen T.D., Harder A., Xiong Y., Kowalec K., Hägg S., Cai N., Kuja-Halkola R., Dalman C., Sullivan P.F., Lu Y. Genetic heterogeneity and subtypes of major depression. Mol. Psychiatry. 2022;27:1667–1675. doi: 10.1038/s41380-021-01413-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-021-01413-6</ArticleId><ArticleId IdType="pmc">PMC9106834</ArticleId><ArticleId IdType="pubmed">34997191</ArticleId></ArticleIdList></Reference><Reference><Citation>Penninx B. Immunometabolic depression: From conceptualization towards implementation. Eur. Psychiatry. 2023;66:S11. doi: 10.1192/j.eurpsy.2023.51.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/j.eurpsy.2023.51</ArticleId></ArticleIdList></Reference><Reference><Citation>Gezsi A., Van der Auwera S., Mäkinen H., Eszlari N., Hullam G., Nagy T., Bonk S., González-Colom R., Gonda X., Garvert L., et al. Unique genetic and risk-factor profiles in clusters of major depressive disorder-related multimorbidity trajectories. Nat. Commun. 2024;15:7190. doi: 10.1038/s41467-024-51467-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-024-51467-7</ArticleId><ArticleId IdType="pmc">PMC11339304</ArticleId><ArticleId IdType="pubmed">39168988</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonda X., Petschner P., Eszlari N., Sutori S., Gal Z., Koncz S., Anderson I.M., Deakin B., Juhasz G., Bagdy G. Effects of Different Stressors Are Modulated by Different Neurobiological Systems: The Role of GABA-A Versus CB1 Receptor Gene Variants in Anxiety and Depression. Front. Cell. Neurosci. 2019;13:138. doi: 10.3389/fncel.2019.00138.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00138</ArticleId><ArticleId IdType="pmc">PMC6467241</ArticleId><ArticleId IdType="pubmed">31024264</ArticleId></ArticleIdList></Reference><Reference><Citation>Beurel E., Toups M., Nemeroff C.B. The Bidirectional Relationship of Depression and Inflammation: Double Trouble. Neuron. 2020;107:234–256. doi: 10.1016/j.neuron.2020.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.06.002</ArticleId><ArticleId IdType="pmc">PMC7381373</ArticleId><ArticleId IdType="pubmed">32553197</ArticleId></ArticleIdList></Reference><Reference><Citation>Sousa G.M.d., Vargas H.D.Q., Barbosa F.F., Galvão-Coelho N.L. Stress, memory, and implications for major depression. Behav. Brain Res. 2021;412:113410. doi: 10.1016/j.bbr.2021.113410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2021.113410</ArticleId><ArticleId IdType="pubmed">34116119</ArticleId></ArticleIdList></Reference><Reference><Citation>Medina-Rodriguez E.M., Beurel E. Blood brain barrier and inflammation in depression. Neurobiol. Dis. 2022;175:105926. doi: 10.1016/j.nbd.2022.105926.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2022.105926</ArticleId><ArticleId IdType="pmc">PMC10035601</ArticleId><ArticleId IdType="pubmed">36375722</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonda X., Hullam G., Antal P., Eszlari N., Petschner P., Hokfelt T.G., Anderson I.M., Deakin J.F.W., Juhasz G., Bagdy G. Significance of risk polymorphisms for depression depends on stress exposure. Sci. Rep. 2018;8:3946. doi: 10.1038/s41598-018-22221-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-22221-z</ArticleId><ArticleId IdType="pmc">PMC5834495</ArticleId><ArticleId IdType="pubmed">29500446</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt F.M., Sander C., Minkwitz J., Mergl R., Dalton B., Holdt L.M., Teupser D., Hegerl U., Himmerich H. Serum Markers of Inflammation Mediate the Positive Association Between Neuroticism and Depression. Front. Psychiatry. 2018;9:609. doi: 10.3389/fpsyt.2018.00609.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2018.00609</ArticleId><ArticleId IdType="pmc">PMC6256194</ArticleId><ArticleId IdType="pubmed">30524320</ArticleId></ArticleIdList></Reference><Reference><Citation>Puvogel S., Alsema A., Kracht L., Webster M.J., Weickert C.S., Sommer I.E.C., Eggen B.J.L. Single-nucleus RNA sequencing of midbrain blood-brain barrier cells in schizophrenia reveals subtle transcriptional changes with overall preservation of cellular proportions and phenotypes. Mol. Psychiatry. 2022;27:4731–4740. doi: 10.1038/s41380-022-01796-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01796-0</ArticleId><ArticleId IdType="pmc">PMC9734060</ArticleId><ArticleId IdType="pubmed">36192459</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia F.J., Sun N., Lee H., Godlewski B., Mathys H., Galani K., Zhou B., Jiang X., Ng A.P., Mantero J., et al. Single-cell dissection of the human brain vasculature. Nature. 2022;603:893–899. doi: 10.1038/s41586-022-04521-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04521-7</ArticleId><ArticleId IdType="pmc">PMC9680899</ArticleId><ArticleId IdType="pubmed">35158371</ArticleId></ArticleIdList></Reference><Reference><Citation>de Kluiver H., Jansen R., Milaneschi Y., Penninx B.W.J.H. Involvement of inflammatory gene expression pathways in depressed patients with hyperphagia. Transl. Psychiatry. 2019;9:193. doi: 10.1038/s41398-019-0528-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-019-0528-0</ArticleId><ArticleId IdType="pmc">PMC6702221</ArticleId><ArticleId IdType="pubmed">31431611</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA. 2005;102:15545–15550. doi: 10.1073/pnas.0506580102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0506580102</ArticleId><ArticleId IdType="pmc">PMC1239896</ArticleId><ArticleId IdType="pubmed">16199517</ArticleId></ArticleIdList></Reference><Reference><Citation>Cain S.A., Woods S., Singh M., Kimber S.J., Baldock C. ADAMTS6 cleaves the large latent TGFβ complex and increases the mechanotension of cells to activate TGFβ. Matrix Biol. 2022;114:18–34. doi: 10.1016/j.matbio.2022.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.matbio.2022.11.001</ArticleId><ArticleId IdType="pubmed">36368447</ArticleId></ArticleIdList></Reference><Reference><Citation>Belonogova N.M., Zorkoltseva I.V., Tsepilov Y.A., Axenovich T.I. Gene-based association analysis identifies 190 genes affecting neuroticism. Sci. Rep. 2021;11:2484. doi: 10.1038/s41598-021-82123-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-82123-5</ArticleId><ArticleId IdType="pmc">PMC7844228</ArticleId><ArticleId IdType="pubmed">33510330</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagel M., Jansen P.R., Stringer S., Watanabe K., de Leeuw C.A., Bryois J., Savage J.E., Hammerschlag A.R., Skene N.G., Muñoz-Manchado A.B., et al. Meta-analysis of genome-wide association studies for neuroticism in 449,484 individuals identifies novel genetic loci and pathways. Nat. Genet. 2018;50:920–927. doi: 10.1038/s41588-018-0151-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0151-7</ArticleId><ArticleId IdType="pubmed">29942085</ArticleId></ArticleIdList></Reference><Reference><Citation>Escudero-Esparza A., Kalchishkova N., Kurbasic E., Jiang W.G., Blom A.M. The novel complement inhibitor human CUB and Sushi multiple domains 1 (CSMD1) protein promotes factor I-mediated degradation of C4b and C3b and inhibits the membrane attack complex assembly. FASEB J. 2013;27:5083–5093. doi: 10.1096/fj.13-230706.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.13-230706</ArticleId><ArticleId IdType="pubmed">23964079</ArticleId></ArticleIdList></Reference><Reference><Citation>Luykx J.J., Bakker S.C., Lentjes E., Neeleman M., Strengman E., Mentink L., DeYoung J., de Jong S., Sul J.H., Eskin E., et al. Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid. Mol. Psychiatry. 2014;19:228–234. doi: 10.1038/mp.2012.183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2012.183</ArticleId><ArticleId IdType="pubmed">23319000</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraus D.M., Elliott G.S., Chute H., Horan T., Pfenninger K.H., Sanford S.D., Foster S., Scully S., Welcher A.A., Holers V.M. CSMD1 Is a Novel Multiple Domain Complement-Regulatory Protein Highly Expressed in the Central Nervous System and Epithelial Tissues. J. Immunol. 2006;176:4419–4430. doi: 10.4049/jimmunol.176.7.4419.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.176.7.4419</ArticleId><ArticleId IdType="pubmed">16547280</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalinowski A., Liliental J., Anker L.A., Linkovski O., Culbertson C., Hall J.N., Pattni R., Sabatti C., Noordsy D., Hallmayer J.F., et al. Increased activation product of complement 4 protein in plasma of individuals with schizophrenia. Transl. Psychiatry. 2021;11:486. doi: 10.1038/s41398-021-01583-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-021-01583-5</ArticleId><ArticleId IdType="pmc">PMC8458380</ArticleId><ArticleId IdType="pubmed">34552056</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard D.M., Adams M.J., Clarke T.-K., Hafferty J.D., Gibson J., Shirali M., Coleman J.R.I., Hagenaars S.P., Ward J., Wigmore E.M., et al. Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat. Neurosci. 2019;22:343–352. doi: 10.1038/s41593-018-0326-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0326-7</ArticleId><ArticleId IdType="pmc">PMC6522363</ArticleId><ArticleId IdType="pubmed">30718901</ArticleId></ArticleIdList></Reference><Reference><Citation>Steen V.M., Nepal C., Ersland K.M., Holdhus R., Nævdal M., Ratvik S.M., Skrede S., Håvik B. Neuropsychological deficits in mice depleted of the schizophrenia susceptibility gene CSMD1. PLoS ONE. 2013;8:e79501. doi: 10.1371/journal.pone.0079501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0079501</ArticleId><ArticleId IdType="pmc">PMC3828352</ArticleId><ArticleId IdType="pubmed">24244513</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma R., Frasch M.G., Zelgert C., Zimmermann P., Fabre B., Wilson R., Waldenberger M., MacDonald J.W., Bammler T.K., Lobmaier S.M., et al. Maternal–fetal stress and DNA methylation signatures in neonatal saliva: An epigenome-wide association study. Clin. Epigenet. 2022;14:87. doi: 10.1186/s13148-022-01310-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-022-01310-x</ArticleId><ArticleId IdType="pmc">PMC9281078</ArticleId><ArticleId IdType="pubmed">35836289</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamagata A., Yoshida T., Sato Y., Goto-Ito S., Uemura T., Maeda A., Shiroshima T., Iwasawa-Okamoto S., Mori H., Mishina M., et al. Mechanisms of splicing-dependent trans-synaptic adhesion by PTPδ–IL1RAPL1/IL-1RAcP for synaptic differentiation. Nat. Commun. 2015;6:6926. doi: 10.1038/ncomms7926.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms7926</ArticleId><ArticleId IdType="pmc">PMC4423211</ArticleId><ArticleId IdType="pubmed">25908590</ArticleId></ArticleIdList></Reference><Reference><Citation>Uhl G.R., Martinez M.J. PTPRD: Neurobiology, genetics, and initial pharmacology of a pleiotropic contributor to brain phenotypes. Ann. N. Y. Acad. Sci. 2019;1451:112–129. doi: 10.1111/nyas.14002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nyas.14002</ArticleId><ArticleId IdType="pmc">PMC6629525</ArticleId><ArticleId IdType="pubmed">30648269</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F., Wang B., Qin T., Wang L., Zhang Q., Lu Y., Song B., Yu X., Li L. IL-6 induces tumor suppressor protein tyrosine phosphatase receptor type D by inhibiting miR-34a to prevent IL-6 signaling overactivation. Mol. Cell. Biochem. 2020;473:1–13. doi: 10.1007/s11010-020-03803-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-020-03803-w</ArticleId><ArticleId IdType="pubmed">32602014</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward J., Strawbridge R.J., Bailey M.E.S., Graham N., Ferguson A., Lyall D.M., Cullen B., Pidgeon L.M., Cavanagh J., Mackay D.F., et al. Genome-wide analysis in UK Biobank identifies four loci associated with mood instability and genetic correlation with major depressive disorder, anxiety disorder and schizophrenia. Transl. Psychiatry. 2017;7:1264. doi: 10.1038/s41398-017-0012-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-017-0012-7</ArticleId><ArticleId IdType="pmc">PMC5802589</ArticleId><ArticleId IdType="pubmed">29187730</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagomäe T., Singh K., Philips M.A., Jayaram M., Seppa K., Tekko T., Gilbert S.F., Vasar E., Lilleväli K. Alternative Promoter Use Governs the Expression of IgLON Cell Adhesion Molecules in Histogenetic Fields of the Embryonic Mouse Brain. Int. J. Mol. Sci. 2021;22:6955. doi: 10.3390/ijms22136955.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22136955</ArticleId><ArticleId IdType="pmc">PMC8268470</ArticleId><ArticleId IdType="pubmed">34203377</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubick N., Flournoy P.C.H., Enciu A.M., Manda G., Mickael M.E. Drugs Modulating CD4+ T Cells Blood–Brain Barrier Interaction in Alzheimer’s Disease. Pharmaceutics. 2020;12:880. doi: 10.3390/pharmaceutics12090880.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics12090880</ArticleId><ArticleId IdType="pmc">PMC7558445</ArticleId><ArticleId IdType="pubmed">32948022</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubick N., Brösamle D., Mickael M.E. Molecular Evolution and Functional Divergence of the IgLON Family. Evol. Bioinform. 2018;14:1176934318775081. doi: 10.1177/1176934318775081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1176934318775081</ArticleId><ArticleId IdType="pmc">PMC5967153</ArticleId><ArticleId IdType="pubmed">29844654</ArticleId></ArticleIdList></Reference><Reference><Citation>Ariss M.M., Terry A.R., Islam A., Hay N., Frolov M.V. Amalgam regulates the receptor tyrosine kinase pathway through Sprouty in glial cell development in the Drosophila larval brain. J. Cell Sci. 2020;133 doi: 10.1242/jcs.250837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.250837</ArticleId><ArticleId IdType="pmc">PMC7541346</ArticleId><ArticleId IdType="pubmed">32878945</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberca C.D., Papale L.A., Madrid A., Gianatiempo O., Cánepa E.T., Alisch R.S., Chertoff M. Perinatal protein malnutrition results in genome-wide disruptions of 5-hydroxymethylcytosine at regions that can be restored to control levels by an enriched environment. Epigenetics. 2021;16:1085–1101. doi: 10.1080/15592294.2020.1841871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15592294.2020.1841871</ArticleId><ArticleId IdType="pmc">PMC8510594</ArticleId><ArticleId IdType="pubmed">33172347</ArticleId></ArticleIdList></Reference><Reference><Citation>Bregin A., Mazitov T., Aug I., Philips M.A., Innos J., Vasar E. Increased sensitivity to psychostimulants and GABAergic drugs in Lsamp-deficient mice. Pharmacol. Biochem. Behav. 2019;183:87–97. doi: 10.1016/j.pbb.2019.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pbb.2019.05.010</ArticleId><ArticleId IdType="pubmed">31163180</ArticleId></ArticleIdList></Reference><Reference><Citation>Carboni L., Pischedda F., Piccoli G., Lauria M., Musazzi L., Popoli M., Mathé A.A., Domenici E. Depression-Associated Gene Negr1-Fgfr2 Pathway Is Altered by Antidepressant Treatment. Cells. 2020;9:1818. doi: 10.3390/cells9081818.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9081818</ArticleId><ArticleId IdType="pmc">PMC7464991</ArticleId><ArticleId IdType="pubmed">32751911</ArticleId></ArticleIdList></Reference><Reference><Citation>Koido K., Traks T., Balõtšev R., Eller T., Must A., Koks S., Maron E., Tõru I., Shlik J., Vasar V., et al. Associations between LSAMP gene polymorphisms and major depressive disorder and panic disorder. Transl. Psychiatry. 2012;2:e152. doi: 10.1038/tp.2012.74.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/tp.2012.74</ArticleId><ArticleId IdType="pmc">PMC3432189</ArticleId><ArticleId IdType="pubmed">22892717</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Long F., Cai B., Chen X., Qin L., Chen G. A Novel Relationship for Schizophrenia, Bipolar, and Major Depressive Disorder. Part 8: A Hint from Chromosome 8 High Density Association Screen. Mol. Neurobiol. 2017;54:5868–5882. doi: 10.1007/s12035-016-0102-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-016-0102-1</ArticleId><ArticleId IdType="pubmed">27660274</ArticleId></ArticleIdList></Reference><Reference><Citation>Karis K., Eskla K.L., Kaare M., Täht K., Tuusov J., Visnapuu T., Innos J., Jayaram M., Timmusk T., Weickert C.S., et al. Altered Expression Profile of IgLON Family of Neural Cell Adhesion Molecules in the Dorsolateral Prefrontal Cortex of Schizophrenic Patients. Front. Mol. Neurosci. 2018;11:8. doi: 10.3389/fnmol.2018.00008.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00008</ArticleId><ArticleId IdType="pmc">PMC5797424</ArticleId><ArticleId IdType="pubmed">29434535</ArticleId></ArticleIdList></Reference><Reference><Citation>Samardžija B., Pavešić Radonja A., Zaharija B., Bergman M., Renner É., Palkovits M., Rubeša G., Bradshaw N.J. Protein Aggregation of NPAS3, Implicated in Mental Illness, Is Not Limited to the V304I Mutation. J. Pers. Med. 2021;11:1070. doi: 10.3390/jpm11111070.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm11111070</ArticleId><ArticleId IdType="pmc">PMC8623263</ArticleId><ArticleId IdType="pubmed">34834422</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J., Perlis R.H., Lee P.H., Rush A.J., Fava M., Sachs G.S., Lieberman J., Hamilton S.P., Sullivan P., Sklar P., et al. Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression. Am. J. Psychiatry. 2010;167:1254–1263. doi: 10.1176/appi.ajp.2010.09091335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.2010.09091335</ArticleId><ArticleId IdType="pmc">PMC3880556</ArticleId><ArticleId IdType="pubmed">20713499</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Fan T., Li X., Liu L., Mao F., Li Y., Miao Z., Zeng C., Song W., Pan J., et al. Npas3 deficiency impairs cortical astrogenesis and induces autistic-like behaviors. Cell Rep. 2022;40:111289. doi: 10.1016/j.celrep.2022.111289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2022.111289</ArticleId><ArticleId IdType="pubmed">36044858</ArticleId></ArticleIdList></Reference><Reference><Citation>Miao Y.S., Zhao Y.Y., Zhao L.N., Wang P., Liu Y.H., Ma J., Xue Y.X. MiR-18a increased the permeability of BTB via RUNX1 mediated down-regulation of ZO-1, occludin and claudin-5. Cell. Signal. 2015;27:156–167. doi: 10.1016/j.cellsig.2014.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2014.10.008</ArticleId><ArticleId IdType="pubmed">25452107</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren S., Wu G., Huang Y., Wang L., Li Y., Zhang Y. MiR-18a Aggravates Intracranial Hemorrhage by Regulating RUNX1-Occludin/ZO-1 Axis to Increase BBB Permeability. J. Stroke Cerebrovasc. Dis. 2021;30:105878. doi: 10.1016/j.jstrokecerebrovasdis.2021.105878.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2021.105878</ArticleId><ArticleId IdType="pubmed">34077824</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto Y., Greene C., Munnich A., Campbell M. The CLDN5 gene at the blood-brain barrier in health and disease. Fluids Barriers CNS. 2023;20:22. doi: 10.1186/s12987-023-00424-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12987-023-00424-5</ArticleId><ArticleId IdType="pmc">PMC10044825</ArticleId><ArticleId IdType="pubmed">36978081</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal Z., Torok D., Gonda X., Eszlari N., Anderson I.M., William Deakin J.F., Juhasz G., Bagdy G., Petschner P. Inflammation and blood-brain barrier in depression: Interaction of CLDN5 and IL6 gene variants in stress-induced depression. Int. J. Neuropsychopharmacol. 2022;26:189–197. doi: 10.1093/ijnp/pyac079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ijnp/pyac079</ArticleId><ArticleId IdType="pmc">PMC10032304</ArticleId><ArticleId IdType="pubmed">36472886</ArticleId></ArticleIdList></Reference><Reference><Citation>Khandelwal N., Dey S.K., Chakravarty S., Kumar A. miR-30 Family miRNAs Mediate the Effect of Chronic Social Defeat Stress on Hippocampal Neurogenesis in Mouse Depression Model. Front. Mol. Neurosci. 2019;12:188. doi: 10.3389/fnmol.2019.00188.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00188</ArticleId><ArticleId IdType="pmc">PMC6694739</ArticleId><ArticleId IdType="pubmed">31440139</ArticleId></ArticleIdList></Reference><Reference><Citation>Wuchty S., Myers A.J., Ramirez-Restrepo M., Huentelman M., Richolt R., Gould F., Harvey P.D., Michopolous V., Steven J.S., Wingo A.P., et al. Integration of peripheral transcriptomics, genomics, and interactomics following trauma identifies causal genes for symptoms of post-traumatic stress and major depression. Mol. Psychiatry. 2021;26:3077–3092. doi: 10.1038/s41380-021-01084-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-021-01084-3</ArticleId><ArticleId IdType="pubmed">33963278</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuehner J.N., Walia N.R., Seong R., Li Y., Martinez-Feduchi P., Yao B. Social defeat stress induces genome-wide 5mC and 5hmC alterations in the mouse brain. G3 Genes|Genomes|Genetics. 2023;13 doi: 10.1093/g3journal/jkad114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/g3journal/jkad114</ArticleId><ArticleId IdType="pmc">PMC10411578</ArticleId><ArticleId IdType="pubmed">37228107</ArticleId></ArticleIdList></Reference><Reference><Citation>Moratti E., Vezzalini M., Tomasello L., Giavarina D., Sorio C. Identification of protein tyrosine phosphatase receptor gamma extracellular domain (sPTPRG) as a natural soluble protein in plasma. PLoS ONE. 2015;10:e0119110. doi: 10.1371/journal.pone.0119110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0119110</ArticleId><ArticleId IdType="pmc">PMC4361625</ArticleId><ArticleId IdType="pubmed">25775014</ArticleId></ArticleIdList></Reference><Reference><Citation>Felger J.C., Lotrich F.E. Inflammatory cytokines in depression: Neurobiological mechanisms and therapeutic implications. Neuroscience. 2013;246:199–229. doi: 10.1016/j.neuroscience.2013.04.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2013.04.060</ArticleId><ArticleId IdType="pmc">PMC3741070</ArticleId><ArticleId IdType="pubmed">23644052</ArticleId></ArticleIdList></Reference><Reference><Citation>Welcome M.O., Mastorakis N.E. Stress-induced blood brain barrier disruption: Molecular mechanisms and signaling pathways. Pharmacol. Res. 2020;157:104769. doi: 10.1016/j.phrs.2020.104769.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2020.104769</ArticleId><ArticleId IdType="pubmed">32275963</ArticleId></ArticleIdList></Reference><Reference><Citation>Schurhoff N., Toborek M. Circadian rhythms in the blood–brain barrier: Impact on neurological disorders and stress responses. Mol. Brain. 2023;16:5. doi: 10.1186/s13041-023-00997-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-023-00997-0</ArticleId><ArticleId IdType="pmc">PMC9835375</ArticleId><ArticleId IdType="pubmed">36635730</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronaldson P.T., Davis T.P. Regulation of blood–brain barrier integrity by microglia in health and disease: A therapeutic opportunity. J. Cereb. Blood Flow. Metab. 2020;40:S6–S24. doi: 10.1177/0271678X20951995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0271678X20951995</ArticleId><ArticleId IdType="pmc">PMC7687032</ArticleId><ArticleId IdType="pubmed">32928017</ArticleId></ArticleIdList></Reference><Reference><Citation>Pujol M., Paskevicius T., Robinson A., Dhillon S., Eggleton P., Ferecskó A.S., Gutowski N., Holley J., Smallwood M., Newcombe J., et al. Endothelial Cell-Derived Soluble CD200 Determines the Ability of Immune Cells to Cross the Blood–Brain Barrier. Int. J. Mol. Sci. 2024;25:9262. doi: 10.3390/ijms25179262.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms25179262</ArticleId><ArticleId IdType="pmc">PMC11395061</ArticleId><ArticleId IdType="pubmed">39273210</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotwica-Mojzych K., Jodłowska-Jędrych B., Mojzych M. CD200:CD200R Interactions and Their Importance in Immunoregulation. Int. J. Mol. Sci. 2021;22:1602. doi: 10.3390/ijms22041602.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22041602</ArticleId><ArticleId IdType="pmc">PMC7915401</ArticleId><ArticleId IdType="pubmed">33562512</ArticleId></ArticleIdList></Reference><Reference><Citation>Drevets W.C., Wittenberg G.M., Bullmore E.T., Manji H.K. Immune targets for therapeutic development in depression: Towards precision medicine. Nat. Rev. Drug Discov. 2022;21:224–244. doi: 10.1038/s41573-021-00368-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41573-021-00368-1</ArticleId><ArticleId IdType="pmc">PMC8763135</ArticleId><ArticleId IdType="pubmed">35039676</ArticleId></ArticleIdList></Reference><Reference><Citation>Sforzini L., Cattaneo A., Ferrari C., Turner L., Mariani N., Enache D., Hastings C., Lombardo G., Nettis M.A., Nikkheslat N., et al. Higher immune-related gene expression in major depression is independent of CRP levels: Results from the BIODEP study. Transl. Psychiatry. 2023;13:185. doi: 10.1038/s41398-023-02438-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-023-02438-x</ArticleId><ArticleId IdType="pmc">PMC10235092</ArticleId><ArticleId IdType="pubmed">37264010</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Yang W., Chen F., Cui L. COVID-19 and cognitive impairment: Neuroinvasive and blood-brain barrier dysfunction. J. Neuroinflamm. 2022;19:222. doi: 10.1186/s12974-022-02579-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-022-02579-8</ArticleId><ArticleId IdType="pmc">PMC9450840</ArticleId><ArticleId IdType="pubmed">36071466</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene C., Connolly R., Brennan D., Laffan A., O’Keeffe E., Zaporojan L., O’Callaghan J., Thomson B., Connolly E., Argue R., et al. Blood–brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat. Neurosci. 2024;27:421–432. doi: 10.1038/s41593-024-01576-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-024-01576-9</ArticleId><ArticleId IdType="pmc">PMC10917679</ArticleId><ArticleId IdType="pubmed">38388736</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M., Iwasaki A. The neurobiology of long COVID. Neuron. 2022;110:3484–3496. doi: 10.1016/j.neuron.2022.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.10.006</ArticleId><ArticleId IdType="pmc">PMC9537254</ArticleId><ArticleId IdType="pubmed">36288726</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunn E.C., Brown R.C., Dai Y., Rosand J., Nugent N.R., Amstadter A.B., Smoller J.W. Genetic determinants of depression: Recent findings and future directions. Harv. Rev. Psychiatry. 2015;23:1–18. doi: 10.1097/HRP.0000000000000054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HRP.0000000000000054</ArticleId><ArticleId IdType="pmc">PMC4309382</ArticleId><ArticleId IdType="pubmed">25563565</ArticleId></ArticleIdList></Reference><Reference><Citation>Bycroft C., Freeman C., Petkova D., Band G., Elliott L.T., Sharp K., Motyer A., Vukcevic D., Delaneau O., O’Connell J., et al. Genome-wide genetic data on ~500,000 UK Biobank participants. bioRxiv. 2017:166298. doi: 10.1101/166298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/166298</ArticleId></ArticleIdList></Reference><Reference><Citation>Bycroft C., Freeman C., Petkova D., Band G., Elliott L.T., Sharp K., Motyer A., Vukcevic D., Delaneau O., O’Connell J., et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562:203–209. doi: 10.1038/s41586-018-0579-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0579-z</ArticleId><ArticleId IdType="pmc">PMC6786975</ArticleId><ArticleId IdType="pubmed">30305743</ArticleId></ArticleIdList></Reference><Reference><Citation>Deakin J.F., Harro J., Anderson I.M. NewMood: A productive European model of collaboration for translational research in depression. Eur. Neuropsychopharmacol. 2011;21:1–2. doi: 10.1016/j.euroneuro.2010.11.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2010.11.008</ArticleId><ArticleId IdType="pubmed">21145708</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K., Spitzer R.L., Williams J.B., Löwe B. The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: A systematic review. Gen. Hosp. Psychiatry. 2010;32:345–359. doi: 10.1016/j.genhosppsych.2010.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genhosppsych.2010.03.006</ArticleId><ArticleId IdType="pubmed">20633738</ArticleId></ArticleIdList></Reference><Reference><Citation>Derogatis L.R. Administration, Scoring, and Procedures Manual. National Computer Systems; Minneapolis, MN, USA: 1993. BSI brief symptom inventory.</Citation></Reference><Reference><Citation>Brugha T., Bebbington P., Tennant C., Hurry J. The List of Threatening Experiences: A subset of 12 life event categories with considerable long-term contextual threat. Psychol. Med. 1985;15:189–194. doi: 10.1017/S003329170002105X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S003329170002105X</ArticleId><ArticleId IdType="pubmed">3991833</ArticleId></ArticleIdList></Reference><Reference><Citation>Welsh S., Peakman T., Sheard S., Almond R. Comparison of DNA quantification methodology used in the DNA extraction protocol for the UK Biobank cohort. BMC Genom. 2017;18:26. doi: 10.1186/s12864-016-3391-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12864-016-3391-x</ArticleId><ArticleId IdType="pmc">PMC5217214</ArticleId><ArticleId IdType="pubmed">28056765</ArticleId></ArticleIdList></Reference><Reference><Citation>Eszlari N., Bruncsics B., Millinghoffer A., Hullam G., Petschner P., Gonda X., Breen G., Antal P., Bagdy G., Deakin J.F.W., et al. Biology of Perseverative Negative Thinking: The Role of Timing and Folate Intake. Nutrients. 2021;13:4396. doi: 10.3390/nu13124396.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13124396</ArticleId><ArticleId IdType="pmc">PMC8703428</ArticleId><ArticleId IdType="pubmed">34959947</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C.C., Chow C.C., Tellier L.C., Vattikuti S., Purcell S.M., Lee J.J. Second-generation PLINK: Rising to the challenge of larger and richer datasets. Gigascience. 2015;4:7. doi: 10.1186/s13742-015-0047-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13742-015-0047-8</ArticleId><ArticleId IdType="pmc">PMC4342193</ArticleId><ArticleId IdType="pubmed">25722852</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C. PLINK 2.0. 2015.  [(accessed on 15 September 2024)].  Available online:  https://www.cog-genomics.org/plink/2.0/</Citation></Reference><Reference><Citation>Watanabe K., Taskesen E., van Bochoven A., Posthuma D. Functional mapping and annotation of genetic associations with FUMA. Nat. Commun. 2017;8:1826. doi: 10.1038/s41467-017-01261-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-01261-5</ArticleId><ArticleId IdType="pmc">PMC5705698</ArticleId><ArticleId IdType="pubmed">29184056</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team . R: A Language and Environment for Statistical Computing, 4.3.0. R Foundation for Statistical Computing; Vienna, Austria: 2022.</Citation></Reference><Reference><Citation>Wickham H., Averick M., Bryan J., Chang W., McGowan L., François R., Grolemund G., Hayes A., Henry L., Hester J., et al. Welcome to the Tidyverse. J. Open Source Softw. 2019;4:1686. doi: 10.21105/joss.01686.</Citation><ArticleIdList><ArticleId IdType="doi">10.21105/joss.01686</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickham H., Chang W., Wickham M.H. Package ‘ggplot2’.  [(accessed on 15 September 2024)];Create Elegant Data Visualisations Using the Grammar of Graphics. 2016 Volume 2:1–189. Available online:  https://cran.r-project.org/web/packages/ggplot2/index.html.</Citation></Reference><Reference><Citation>Ram K., Wickham H.  wesanderson: A Wes Anderson Palette Generator. 2018.  [(accessed on 15 September 2024)].  R package version 0.3.6. Available online:  https://cran.r-project.org/web/packages/wesanderson/index.html.</Citation></Reference><Reference><Citation>Li L.-Y.  CMplot: Circle Manhattan Plot. 2023.  [(accessed on 15 September 2024)].  R package version 4.3.1. Available online:  https://cran.r-project.org/web/packages/CMplot/index.html.</Citation></Reference><Reference><Citation>Long J.A.  jtools: Analysis and Presentation of Social Scientific Data. 2020.  [(accessed on 15 September 2024)].  R package version 2.1.0. Available online:  https://cran.r-project.org/web/packages/jtools/index.html.</Citation></Reference><Reference><Citation>Noumbissi M.E., Galasso B., Stins M.F. Brain vascular heterogeneity: Implications for disease pathogenesis and design of in vitro blood–brain barrier models. Fluids Barriers CNS. 2018;15:12. doi: 10.1186/s12987-018-0097-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12987-018-0097-2</ArticleId><ArticleId IdType="pmc">PMC5911972</ArticleId><ArticleId IdType="pubmed">29688865</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaeffer S., Iadecola C. Revisiting the neurovascular unit. Nat. Neurosci. 2021;24:1198–1209. doi: 10.1038/s41593-021-00904-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-00904-7</ArticleId><ArticleId IdType="pmc">PMC9462551</ArticleId><ArticleId IdType="pubmed">34354283</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>